Renal replacement therapy in Europe: a summary of the 2011 ERA–EDTA Registry Annual Report


BACKGROUND This article provides a summary of the 2011 ERA-EDTA Registry Annual Report (available at METHODS Data on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. From 27 registries, individual patient data were received, whereas 17 registries contributed data in aggregated form. We present the incidence and prevalence of RRT, and renal transplant rates in 2011. In addition, survival probabilities and expected remaining lifetimes were calculated for those registries providing individual patient data. RESULTS The overall unadjusted incidence rate of RRT in 2011 among all registries reporting to the ERA-EDTA Registry was 117 per million population (pmp) (n = 71.631). Incidence rates varied from 24 pmp in Ukraine to 238 pmp in Turkey. The overall unadjusted prevalence of RRT for ESRD on 31 December 2011 was 692 pmp (n = 425 824). The highest prevalence was reported by Portugal (1662 pmp) and the lowest by Ukraine (131 pmp). Among all registries, a total of 22 814 renal transplantations were performed (37 pmp). The highest overall transplant rate was reported from Spain, Cantabria (81 pmp), whereas the highest rate of living donor transplants was reported from Turkey (39 pmp). For patients who started RRT between 2002 and 2006, the unadjusted 5-year patient survival on RRT was 46.8% [95% confidence interval (CI) 46.6-47.0], and on dialysis 39.3% (95% CI 39.2-39.4). The unadjusted 5-year patient survival after the first renal transplantation performed between 2002 and 2006 was 86.7% (95% CI 86.2-87.2) for kidneys from deceased donors and 94.3% (95% CI 93.6-95.0) for kidneys from living donors.

DOI: 10.1093/ckj/sfu007

Extracted Key Phrases

16 Figures and Tables

Citations per Year

54 Citations

Semantic Scholar estimates that this publication has 54 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Noordzij2014RenalRT, title={Renal replacement therapy in Europe: a summary of the 2011 ERA–EDTA Registry Annual Report}, author={Marlies Noordzij and Anneke Kramer and Jos{\'e} Mar{\'i}a Abad D{\'i}ez and Ram{\'o}n Alonso de la Torre and Emma Arcos Fuster and Boris T. Bikbov and Marjolein Bonthuis and Encarnaci{\'o}n Bouzas Caama{\~n}o and Svetlana {\vC}ala and Fergus J. Caskey and Pablo Castro de la Nuez and Harijs Cernevskis and Fr{\'e}d{\'e}ric Collart and Rafael D{\'i}az Tejeiro and Ljubica D Djukanovic and Manuel Ferrer-Alamar and Patrik Finne and Mar{\'i}a de los Angelos Garc{\'i}a Bazaga and Liliana G{\^a}rneaţă and Eliezer Golan and Raquel Gonz{\'a}lez Fern{\'a}ndez and James Goya Heaf and Andries J. Hoitsma and George Ioannidis and Mykola Kolesnyk and Reinhard Kramar and Mathilde Lasalle and Torbj\orn Leivestad and Franti{\vs}ek Lopot and Moniek W. M. van de Luijtgaarden and Fernando Mac{\'a}rio and {\'A}ngela Magaz and Eduardo Mart{\'i}n Escobar and Johan M J De Meester and Wendy Metcalfe and Mai Ots-Rosenberg and Run{\'o}lfur P{\'a}lsson and Celestino Pi{\~n}era and Maria Pippias and Karl G{\"{o}ran Pr{\"{u}tz and Marina Mugosa Ratkovi{\'c} and Halima Resi{\'c} and Aurelio Rodr{\'i}guez Hern{\'a}ndez and Bolesław Rutkowski and Viera Spustov{\'a} and Vianda S. Stel and Olivera Stojceva-Taneva and G{\"{u}ltekin S{\"{u}leymanlar and Christoph Wanner and Kitty J. Jager}, booktitle={Clinical kidney journal}, year={2014} }